AceRNA
Signal active
Organization
Contact Information
Overview
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
About
Industries
Biotechnology, Life Science, Health Care, Biopharma, Therapeutics, Genetics
Founded
2018
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
AceRNA headquartered in Asia, operates in the Biotechnology, Life Science, Health Care, Biopharma, Therapeutics, Genetics sector. The company focuses on Biotechnology and has secured $185.3M in funding across 72 round(s). With a team of 11-50 employees, AceRNA is actively contributing to advancements in Biotechnology. Their latest funding round, Angel Round - AceRNA, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
2
Lead Investors
0
Total Funding Amount
$2.6M
Details
3
AceRNA has raised a total of $2.6M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | 702.8K | ||
| 2019 | Early Stage Venture | 1.9M | ||
| 2020 | Seed |
Investors
AceRNA is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| SMBC Venture Capital | - | FUNDING ROUND - SMBC Venture Capital | 1.9M |
| Hidetoshi Takano | - | FUNDING ROUND - Hidetoshi Takano | undefined |
| AceRNA | - | FUNDING ROUND - AceRNA | undefined |
| Hirofumi Miki | - | FUNDING ROUND - Hirofumi Miki | undefined |
Recent Activity
There is no recent news or activity for this profile.